295 related articles for article (PubMed ID: 2448139)
21. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W; Huang Z; Tan SH; O'Connor MJ; Bernard HU
J Virol; 2000 Mar; 74(6):2489-501. PubMed ID: 10684263
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
Bouvard V; Storey A; Pim D; Banks L
EMBO J; 1994 Nov; 13(22):5451-9. PubMed ID: 7957111
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.
Romanczuk H; Thierry F; Howley PM
J Virol; 1990 Jun; 64(6):2849-59. PubMed ID: 2159546
[TBL] [Abstract][Full Text] [Related]
24. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.
Tornesello ML; Buonaguro FM; Buonaguro L; Salatiello I; Beth-Giraldo E; Giraldo G
J Gen Virol; 2000 Dec; 81(Pt 12):2969-2982. PubMed ID: 11086128
[TBL] [Abstract][Full Text] [Related]
25. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
26. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
27. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
28. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
29. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.
Gloss B; Bernard HU; Seedorf K; Klock G
EMBO J; 1987 Dec; 6(12):3735-43. PubMed ID: 2828035
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.
Johung K; Goodwin EC; DiMaio D
J Virol; 2007 Mar; 81(5):2102-16. PubMed ID: 17182682
[TBL] [Abstract][Full Text] [Related]
31. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
32. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.
Gius D; Grossman S; Bedell MA; Laimins LA
J Virol; 1988 Mar; 62(3):665-72. PubMed ID: 2828662
[TBL] [Abstract][Full Text] [Related]
33. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.
Thierry F; Yaniv M
EMBO J; 1987 Nov; 6(11):3391-7. PubMed ID: 2828029
[TBL] [Abstract][Full Text] [Related]
34. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity.
Romanczuk H; Howley PM
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3159-63. PubMed ID: 1313584
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
36. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
May M; Dong XP; Beyer-Finkler E; Stubenrauch F; Fuchs PG; Pfister H
EMBO J; 1994 Mar; 13(6):1460-6. PubMed ID: 8137827
[TBL] [Abstract][Full Text] [Related]
37. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.
Spalholz BA; Yang YC; Howley PM
Cell; 1985 Aug; 42(1):183-91. PubMed ID: 2990724
[TBL] [Abstract][Full Text] [Related]
38. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
39. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
40. Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.
Sen E; Alam S; Meyers C
J Virol; 2004 Jan; 78(2):612-29. PubMed ID: 14694093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
